Is AVR or BBLG more undervalued in 2026?

CirclFi compares Anteris Technologies Global Cor (AVR) and Bone Biologics Corp (BBLG) using 13 institutional-grade valuation models. AVR has a Quality of Company score of 6.1/10 while BBLG scores 3.7/10.

Which is a better buy — AVR or BBLG?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do AVR and BBLG valuations compare?

AVR at $8.62 and BBLG at $1.32 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

AVR vs BBLG Valuation Comparison 2026 — Intrinsic Value Analysis

AVR

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Anteris Technologies Global Cor

Quality

6.1

out of 10

Value Trap

—

Price

$8.62

Last close

Models

10/13

Active

BBLG

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Bone Biologics Corp

Quality

3.7

out of 10

Value Trap

SAFE

Price

$1.32

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	AVR Fair Value	AVR Upside	BBLG Fair Value	BBLG Upside
Bayesian DCF	Intrinsic	$3.92	-54.5%	$1.71	+29.7%
Earnings Power Value	Intrinsic	$0.34	-94.6%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	—	—	$0.30	-76.9%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for AVR vs BBLG — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

AVR vs BBLG — Which Stock Is More Undervalued?

AVR scores higher with a 6.1/10 quality rating vs BBLG's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Anteris Technologies Global Cor (AVR) and Bone Biologics Corp (BBLG) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

AVR currently trades at $8.62 with a QOC of 6.1/10, while BBLG trades at $1.32 with a QOC of 3.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).